Report Content

Chapter 1   Methodology

1.1    Methodology

1.2    Market definition

1.3    Forecast parameters

1.4    Data sources

1.4.1    Secondary

1.4.1.1    Paid sources

1.4.1.2    Unpaid sources

1.4.2    Primary

Chapter 2   Executive Summary

2.1    North America orthopedic devices industry 360⁰ synopsis, 2016 - 2027

2.1.1    Country trends

2.1.2    Product trends

Chapter 3   North America Orthopedic Devices Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2016 - 2027

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Growing base of geriatric population

3.3.1.2    Augmented incidence of orthopedic diseases

3.3.1.3    Technological advancements

3.3.1.4    Escalating rate of orthopedic surgeries

3.3.2    Industry pitfalls & challenges

3.3.2.1    Excessive cost of orthopedic devices

3.3.2.2    Stringent FDA regulations and biocompatibility issues

3.3.2.3    Post-surgery complications

3.4    Analysis of COVID-19 impact on the industry

3.5    Porter’s analysis

3.6    Competitive landscape, 2020

3.7    PEST analysis

Chapter 4   North America Orthopedic Devices Market, By Product

4.1    Market trends

4.2    Joint reconstruction devices

4.2.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

4.2.2    Hip replacement

4.2.2.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.2.3    Knee replacement

4.2.3.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.2.4    Ankle replacement

4.2.4.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.2.5    Shoulder replacement

4.2.5.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.2.6    Others

4.2.6.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.3    Spinal devices

4.3.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.4    Trauma fixation devices

4.4.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.5    Orthobiologics

4.5.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.6    Arthroscopic devices

4.6.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.7    Others

4.7.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

Chapter 5   North America Orthopedic Devices Market, By Country

5.1    Market trends

5.2    U.S.

5.2.1    Market estimate and forecast, by product, 2016 - 2027 (USD Million)

5.2.1.1    Market estimate and forecast, by joint reconstruction devices, 2016– 2027 (USD Million)

5.3    Canada

5.3.1    Market estimate and forecast, by product, 2016 - 2027 (USD Million)

5.3.1.1    Market estimate and forecast, by joint reconstruction devices, 2016– 2027 (USD Million)

Chapter 6   Company Profiles

6.1    aap Implantate AG

6.1.1    Business overview

6.1.2    Financial data

6.1.3    Product landscape

6.1.4    Strategic outlook

6.1.5    SWOT analysis

6.2    Alphatec Spine Inc.

6.2.1    Business overview

6.2.2    Financial data

6.2.3    Product landscape

6.2.4    Strategic outlook

6.2.5    SWOT analysis

6.3    Arthrex

6.3.1    Business overview

6.3.2    Financial data

6.3.3    Product landscape

6.3.4    Strategic outlook

6.3.5    SWOT analysis

6.4    B. Braun Melsungen AG

6.4.1    Business overview

6.4.2    Financial data

6.4.3    Product landscape

6.4.4    Strategic outlook

6.4.5    SWOT analysis

6.5    ConforMIS, Inc.

6.5.1    Business overview

6.5.2    Financial data

6.5.3    Product landscape

6.5.4    Strategic outlook

6.5.5    SWOT analysis

6.6    CONMED Corporation

6.6.1    Business overview

6.6.2    Financial data

6.6.3    Product landscape

6.6.4    Strategic outlook

6.6.5    SWOT analysis

6.7    DePuy Synthes (Johnson and Johnson)

6.7.1    Business overview

6.7.2    Financial data

6.7.3    Product landscape

6.7.4    Strategic outlook

6.7.5    SWOT analysis

6.8    DJO Global

6.8.1    Business overview

6.8.2    Financial data

6.8.3    Product landscape

6.8.4    Strategic outlook

6.8.5    SWOT analysis

6.9    Globus Medical

6.9.1    Business overview

6.9.2    Financial data

6.9.3    Product landscape

6.9.4    Strategic outlook

6.9.5    SWOT analysis

6.10    Integra LifeSciences

6.10.1    Business overview

6.10.2    Financial data

6.10.3    Product landscape

6.10.4    Strategic outlook

6.10.5    SWOT analysis

6.11    Medacta

6.11.1    Business overview

6.11.2    Financial data

6.11.3    Product landscape

6.11.4    Strategic outlook

6.11.5    SWOT analysis

6.12    Medtronic

6.12.1    Business overview

6.12.2    Financial data

6.12.3    Product landscape

6.12.4    Strategic outlook

6.12.5    SWOT analysis

6.13    Microport Scientific Corporation

6.13.1    Business overview

6.13.2    Financial data

6.13.3    Product landscape

6.13.4    Strategic outlook

6.13.5    SWOT analysis

6.14    NuVasive

6.14.1    Business overview

6.14.2    Financial data

6.14.3    Product landscape

6.14.4    Strategic outlook

6.14.5    SWOT analysis

6.15    Smith & Nephew

6.15.1    Business overview

6.15.2    Financial data

6.15.3    Product landscape

6.15.4    Strategic outlook

6.15.5    SWOT analysis

6.16    Stryker

6.16.1    Business overview

6.16.2    Financial data

6.16.3    Product landscape

6.16.4    Strategic outlook

6.16.5    SWOT analysis

6.17    TriMed Inc.

6.17.1    Business overview

6.17.2    Financial data

6.17.3    Product landscape

6.17.4    Strategic outlook

6.17.5    SWOT analysis

6.18    Waldemar LINK

6.18.1    Business overview

6.18.2    Financial data

6.18.3    Product landscape

6.18.4    Strategic outlook

6.18.5    SWOT analysis

6.19    Zimmer Biomet

6.19.1    Business overview

6.19.2    Financial data

6.19.3    Product landscape

6.19.4    Strategic outlook

6.19.5    SWOT analysis